October 24, 2015 FDA approves new drug to treat ulcerative colitis The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.
October 24, 2015 New clot preventer works as well as warfarin with less bleeding The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and caused far less bleeding, according to data from a large clinical trial.
October 24, 2015 Plant 'milkers' seek molecules for medicines and makeup A quiet village in eastern France is home to an unusual greenhouse.
October 24, 2015 Joan Rivers' hospitalization: Risk of complications from endoscopic procedures usually low Comedian Joan Rivers was admitted to Mount Sinai Hospital in New York City Thursday in critical condition, after reportedly undergoing a minor endoscopic procedure at a medical clinic.
October 24, 2015 1 in 10 Americans have taken drugs prescribed for others, poll finds One in 10 Americans admit taking a prescription drug they have not been prescribed, and a quarter of those people have used them just to get high.
October 24, 2015 Medication nation: Study shows significant overuse of antibiotics U.S. doctors are prescribing enough antibiotics to give them to 4 out of 5 Americans every year, an alarming pace that suggests they are being overused, a new government study finds
October 24, 2015 Bayer heart failure drug cuts deaths in mid-stage trial Bayer will move a heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular treatments after the experimental medicine showed a "striking" reduction in deaths in a mid-stage trial.
October 24, 2015 Study links high sodium "fizzy" medicines to raised heart risks Millions of patients worldwide taking effervescent, dispersible and soluble medicines have an increased risk of heart attacks and strokes because of the high salt content of such drugs, scientists said on Wednesday.
October 24, 2015 FDA approves $1,000-a-day hepatitis C pill U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi as a potentially easier cure for chronic infection with the liver-destroying hepatitis C virus.
October 24, 2015 FDA warns against counterfeit male sexual enhancement product The Food and Drug Administration warned on Tuesday of a counterfeit dietary supplement for male sexual enhancement that could be particularly harmful to patients with diabetes, high blood pressure, high cholesterol and heart disease.
